Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
397.5 USD -0.06% Intraday chart for Vertex Pharmaceuticals Incorporated +0.81% -2.31%
04-26 Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants MT
04-26 Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VERTEX PHARMACEUTICALS INCORPORATED
Bio Therapeutic Drugs
-0.06%+0.81%-2.31%+17.12%+129.96% 103B
Bearish
Neutral
Bullish
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Charts Vertex Pharmaceuticals Incorporated
  5. Relative Strength Chart